Request Demo
Last update 28 May 2025
Diphenhydramine Hydrochloride/Naproxen Sodium
Last update 28 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Naproxen Sodium/Diphenhydramine Hydrochloride, Aleve Pm |
Target |
Action inhibitors, inverse agonists |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H1 receptor inverse agonists(Histamine H1 receptor inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (17 Jan 2014), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC14H14NaO3 |
InChIKeyCNQOEXOJUIMDHW-FVGYRXGTSA-N |
CAS Registry26159-34-2 |
View All Structures (2)
Related
8
Clinical Trials associated with Diphenhydramine Hydrochloride/Naproxen SodiumNCT04307940
A Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Analgesic Efficacy and Safety of Naproxen Sodium Tablets and Hydrocodone/Acetaminophen Tablets in Postsurgical Dental Pain
NCT03570554
A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale
NCT03448536
A Double-Blind, Randomized, Crossover Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea
100 Clinical Results associated with Diphenhydramine Hydrochloride/Naproxen Sodium
Login to view more data
100 Translational Medicine associated with Diphenhydramine Hydrochloride/Naproxen Sodium
Login to view more data
100 Patents (Medical) associated with Diphenhydramine Hydrochloride/Naproxen Sodium
Login to view more data
100 Deals associated with Diphenhydramine Hydrochloride/Naproxen Sodium
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Diphenhydramine Hydrochloride/Naproxen Sodium | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Sleep Initiation and Maintenance Disorders | United States | 17 Jan 2014 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 4 | 221 | (Naproxen Sodium) | iifjxpfjvw(diknvuwugt) = caifagrfpu pnuruxuhfx (iyfantwhew, 3.09) View more | - | 07 Oct 2021 | ||
Placebo (Placebo) | iifjxpfjvw(diknvuwugt) = drcftddwps pnuruxuhfx (iyfantwhew, 4.35) View more | ||||||
Phase 4 | 387 | (Naproxen Sodium (Aleve, BAY117031)) | qhzroyahtp = mpjjlgdbvj ynwbalyhmu (rumkurmnrw, fqnypvnnwa - qoxuaybsju) View more | - | 18 Jul 2019 | ||
qhzroyahtp = suzulwtiyb ynwbalyhmu (rumkurmnrw, kycdumyldd - tyvoswktwy) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free